Drug Discovery Program leader

Responsibilities

• Lead multiple drug discovery programs from target identification through hit and lead optimization, ensuring delivery against scientific, timeline, and business objectives.
• Define program strategy, milestones, success criteria, and execution plans aligned with AQEMIA’s pipeline priorities and company goals.
• Coordinate multidisciplinary teams across chemistry, biology, computational sciences, AI, and platform functions to drive program success.
• Drive high‑quality scientific decision‑making, including prioritization, go/no‑go recommendations, and strategic pivots based on emerging data.
• Anticipate, assess, and mitigate scientific, operational, and pipeline risks while balancing ambition, feasibility, and impact.
• Build and develop high‑performing cross‑functional teams by fostering accountability, collaboration, scientific excellence, and continuous growth.
• Establish effective program governance, monitor progress, optimize resource allocation, and remove execution bottlenecks to ensure timely delivery.
• Capture learnings and drive continuous improvement by providing feedback to platform and scientific teams, promoting best practices, and maximizing platform impact across programs.
• Hands‑on experience in project management: 4+ years of consulting experience and/or 6+ years of project management experience in a fast‑growing environment.
• Scientific background (Master’s degree in a science field) in any scientific discipline such as engineering, machine learning, chemistry, or biology.
• Objective‑driven mindset and a high degree of organization, commitment, and drive.

Preferred Mindset

• Eager to play an active role in contributing to AQEMIA’s strategy to develop drugs for patients.
• Eager to bring a wealth of knowledge to inspire and coach brilliant people from diverse backgrounds.
• Keen to solve tough problems on issues that truly matter, with a proactive and can‑do attitude.
• Team player in a fast‑paced, interdisciplinary environment that keeps everyone on track.

Benefits

• Expanding drug discovery pipeline: focused on critical therapeutic areas such as oncology, CNS, and immuno‑inflammation, with in‑vivo proof‑of‑concept/patent‑stage programs and collaborations with top pharma.
• World‑class interdisciplinary team: work alongside exceptional talent at the intersection of AI, physics‑based modeling, biology, and medicinal chemistry.
• Deep

  Tech recognition: part of French Tech 120 and France 2030, highlighting our role as a key player in Europe’s Deep

  Tech ecosystem.
• Prime location with flexibility: offices in Paris and London (King’s Cross), with flexible work arrangements including up to two remote days per week.
• Strong financial backing: $100M raised from leading European and international investors.